AWT030

N/A

Report date: 2023/06/19 15:44:34

Base Information

Drug NameAWT030
Drug Alias NameAWT030AWT-030
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 21 Receptor agonists
TargetsInterleukin 21 Receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnwita Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnwita Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A